COVID-19 Pandemic and Angina Pectoris: What If the Pain Pathway Is Pharmaceutically Modulated?
Pain Med
.
2020 Nov 1;21(11):3246-3247.
doi: 10.1093/pm/pnaa300.
Authors
Eftychios Siniorakis
1
,
Spyridon Arvanitakis
1
,
Titika Sfakianaki
1
,
Antonis Katsianis
1
,
Georgia Konstantopoulou
2
,
Veneta Papagiannopoulou
1
Affiliations
1
Department of OR Cardiology, Sotiria Chest Diseases Hospital (Reference Hospital for COVID-19 pandemic), Athens, Greece.
2
Department of Pain Medicine, Sotiria Chest Diseases Hospital, Athens, Greece.
PMID:
32893306
PMCID:
PMC7499718
DOI:
10.1093/pm/pnaa300
No abstract available
Publication types
Letter
Comment
MeSH terms
Angina Pectoris / epidemiology
COVID-19*
China
Humans
Pain
Pain Management
Pandemics*
SARS-CoV-2